Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GE vs GSK✓SelectedUSD · GSKGE vs GSK performance historyLatest closeAs of-2.00%11/16
Stock and ETF performance explorer

GE vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+417.6%
GSK return
+46.9%
Excess return
+370.7%
Maximum drawdown
-40.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.0%-0.1%-1.9%-2.0%
7D-3.1%-1.3%-1.8%-2.8%
30D+3.6%+2.7%+0.9%+2.9%
3M-11.6%+2.7%-14.3%-12.3%
6M+15.8%+3.3%+12.5%+14.4%
YTD+6.0%+6.5%-0.4%+4.4%
1Y+7.3%+10.7%-3.4%+4.7%
3Y+248.5%+64.4%+184.1%+201.1%
5Y+417.6%+46.7%+370.9%+327.7%
All+417.6%+46.9%+370.7%+327.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling